epi-Ivermectin B1a (Synonyms: 2-dehydro-4-dihydro Avermectin B1a, epi-dihydro Avermectin B1a, 22,23-dihydro Avermectin B1a) |
| Catalog No.GC41008 |
epi-Ivermectin B1a is a degradation product formed by the reversible base-catalyzed isomerization of ivermectin B1a.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
epi-Ivermectin B1a is a degradation product formed by the reversible base-catalyzed isomerization of ivermectin B1a . It is less active than ivermectin against T. urticae (LC90s = 4.0 and 0.038 ppm, respectively).
Review for epi-Ivermectin B1a
Average Rating: 5 (Based on Reviews and 14 reference(s) in Google Scholar.)
Review for epi-Ivermectin B1a
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *